Yashraj Biotechnology GmbH of Berlin at MEDICA 2017 in Düsseldorf -- COMPAMED Trade Fair
Manufacturers Trader Service

Yashraj Biotechnology GmbH

Uhlandstr. 20-25, 10623 Berlin
Germany

Telephone +49 162 7644212
mukesh@yashrajbio.com

This company is co-exhibitor of
DiagnostikNet-BB Netzwerk Diagnostik Berlin-Brandenburg e.V.

Hall map

MEDICA 2017 hall map (Hall 3): stand H35

Fairground map

MEDICA 2017 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.11  Controls / Standards / Calibrators clinical chemistry

Controls / Standards / Calibrators clinical chemistry

Our products

Product category: Controls / Standards / Calibrators clinical chemistry

CRP High Pure

C-reactive protein (CRP) is a biomarker for inflammation in the human body. The elevation of CRP has also been linked to pathophysiology of atherosclerosis and risk to heart disease. In more than 30 epidemiological studies, CPR has been linked with cardiovascular risk. CRP is believed to be a positive acute phase protein and biomarker of systemic inflammation. It increases in response to various types of injury. In comparison to other acute phase markers, its levels are quite stable, with no significant daily variation, and can thus be precisely measured.
Form: Liquid
Source: Human fluids

More Less

Product category: Controls / Standards / Calibrators clinical chemistry

FABP3

Fatty Acid Binding Protein is a plasma marker of acute myocardial infarction (AMI). The plasma kinetics of FABP3 closely resemble those of myoglobin in that elevated plasma concentrations are found within 2 hours after AMI and return to normal generally within 18 to 24 hours. But the concentration of FABP in the skeletuscle is 20 times lower than in cardiac tissue (for myoglobin the same content for cardiac and skeletal tissue), that makes FABP3 to be more cardiac specific than myoglobin. This makes FABP3 a useful biochemical marker for the early assessment or exclusion of AMI. FABP also appears to be a useful plasma marker for the estimation of myocardial infarct size.
Source: Recombinant (Transformed E.coli)
Species: Human
Accession: P05413.4 (133 AA with 6x His tag)

More Less

Product category: Controls / Standards / Calibrators clinical chemistry

Monoclonal Antibody

CRP is an acute phase protein synthesized by liver and found in blood in response to inflammation. An elevated level of the protein is an indicator of damaged liver, heart and other tissues. The mouse monoclonal antibody has been generated against native CRP antigen. We have two match pairs available with us for CRP detection.
Antigen: Human CRP
Host: Mouse
Isotype: IgG1

More Less

Product category: Controls / Standards / Calibrators clinical chemistry

HBsAg-Ad

Hepatitis B virus is a member of the Hepadnavirus family. Virion diameter of this virus is 22 nm. Lipid and protein form part of the surface of the virion, which is known as the surface antigen HBsAg. HBsAg is one of the first serum markers to appear during the course of HBV infection. HBsAg is a glycosylated lipoprotein, which is shed in large quantities in the serum of infected individuals. In addition to hepatitis, infection with HBV can also lead to cirrhosis and hepatocellular carcinoma. HBsAg-Ad is a surface antigen for Hepatitis B virus of subtype Ad (HbsAg-Ad). In the US, northern Europe and Asia, the ‘d’ determinant is found at a higher frequency.
Form: Liquid
Source: Human blood (non-Indian origin)

More Less

Product category: Controls / Standards / Calibrators clinical chemistry

Neuron Specific Enolase

It is an enzyme of glycolytic pathway. This enzyme is released in the cerebrospinal fluid (CSF) during neuronal injury. It is also a very useful biomarker for detection of neuroblastoma in the tumor patients.
Source: Recombinant (Transformed E.coli)
Species: Human
Accession: P09104

More Less

About us

Company details

Yashraj Biotechnology Limited (YBL) is a part of the “YASHRAJ GROUP” having diversified interests in finance, construction, agriculture, chemicals and biotechnology. YBL was established in 1999 with a mission to achieve excellence in biotechnology and utilize its power for the good of humanity.

More Less